Thus, investigating multiple mRNA marker profiles would be beneficial to improve the sensitivity of PLA1A as a single diagnostic marker or as a novel component in the immunohistochemical panel of metastatic melanomas. This evidence concerns the gene PLA1A and metastatic melanoma.